The Cartilage Guide
PromisingExercise & Rehab · Principles

Load management

Promising · 11 studies cited · 3 min · Updated 2026-09-08

In short: The operating system for every exercise entry here: pain up to about 5/10 that settles by the next morning is acceptable; load spikes relative to recent weeks are the real hazard; total rest is itself a harmful dose. The monitoring rules come from a tendon RCT — their use for cartilage is principled extrapolation, and we say so.

Tissue adapts to the loads it is progressively exposed to; harm follows spikes in load relative to preparedness, not load itself. Two things are established at the two ends of the range. Complete unloading thins cartilage measurably within weeks to months, and structured exercise does not raise biomarkers of cartilage breakdown — in the one trial to vary intensity in osteoarthritic knees, the hardest-working arm saw them fall furthest. Pain during sensible loading does not equal damage. The question is how to dose it, and the best-tested answer is a monitoring system rather than a fixed program.

The pain-monitoring trial

In a randomized trial of 38 people with Achilles tendinopathy, one group was allowed to keep training with pain up to 5/10 — provided it settled by the next morning and wasn't worsening week to week — while the other rested for six weeks first. The continue-training group recovered just as fully (VISA-A 57→85 vs 57→91, no significant differences), with no harm. This is the origin of the "acceptable pain, 24-hour rule" used throughout this section.

The rules, as used on this site

  1. Traffic-light pain scale. 0–2/10 is safe, 3–5/10 is acceptable, above 5/10 is too much.
  2. The 24-hour rule. Pain and swelling should return to baseline by the next morning. If they haven't, the dose was too high — reduce, don't stop.
  3. Progress one variable at a time — load, volume, or frequency — and avoid spikes relative to your recent weeks of training.
  4. Total rest is itself a harmful dose. Complete unloading thins cartilage measurably within weeks to months.

The supporting dose data agree with the structure. Across 217 randomised trials and 15,684 people with knee osteoarthritis, every exercise modality tested beat doing nothing on at least one outcome, and aerobic exercise ranked first overall; in a separate network of 46 resistance-training trials, all seven training types relieved pain against control. In an OA cohort each additional 1,000 daily steps predicted a 16–18% lower risk of functional decline. What no trial supports is a threshold below which exercise stops counting — the consistent finding is that structured, supervised, regular loading works and sporadic loading works less well.

The limits of this extrapolation

The pain-monitoring RCT is a tendon study. No trial validates the 5/10-and-settles thresholds for cartilage lesions or OA — applying them there is principled extrapolation, which is exactly why this entry is promising rather than strong. The acute:chronic workload ratio popularized in sports science has been criticized on statistical grounds; treat "avoid spikes" as a heuristic, not a metric to compute. And effusion and irritability after cartilage repair may not follow tendon-style pain rules — post-operative protocols override these generic rules entirely (see the post-op rehab entry).

Safety and red flags

Monitored loading produced no worse outcomes than rest in the RCT, exercise shows no cartilage-damage signal on imaging across 9 RCTs, and degradation biomarkers mostly fall or stay flat across 12 RCTs. But some signals override the model rather than feed into it: increasing swelling, night pain, or mechanical locking warrant clinical evaluation, not another week of titration. That escalation advice is standard clinical practice, not trial-derived.

Open questions

An RCT of pain-monitoring rules in knee OA or post-cartilage-repair populations is the obvious gap — along with whether morning-after effusion, rather than pain, is the better dial for cartilage patients.

Why this tier? The 24-hour pain-monitoring rule has direct RCT support in Achilles tendinopathy (n=38), and graded exposure is coherent with the human intensity and biomarker data. But no RCT has tested pain-monitoring rules in cartilage-defect or OA populations specifically, so this stays promising.

Key studies

  • RCT · 2007 · n=38

    Promising
    Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study

    Continuing to train within defined pain limits produced no worse outcomes than rest at any timepoint over 12 months — moderate, monitored pain during loading is tolerable; the harm signal belongs to sharp/escalating pain, not all pain.

  • RCT · 2026 · n=120

    Promising
    Effect of aerobic exercise of different intensity on articular cartilage metabolism in patients with knee osteoarthritis: A randomized controlled trial

    A human dose-response trial, and within the range it tested more was better rather than moderate being best. Serum CTX-II and COMP were the primary endpoints and both showed a significant time-by-group interaction (p<0.001). At 12 weeks against their own baselines, CTX-II fell 28.5 percent at high intensity (p<0.001), 18.7 percent at moderate (p<0.01) and 8.2 percent at low (p<0.05), while the control group did not change significantly; COMP fell 22.3 percent at high intensity. WOMAC improved 45.3 percent and pain 52.5 percent in the high-intensity arm, where 73 percent reached the minimal clinically important difference on WOMAC and 80 percent on the pain scale. MRI showed cartilage thickness up 4.2 percent and volume up 3.8 percent at high intensity. The overall dose-response was confirmed at F(3,108)=4.82, p=0.003. No serious adverse events occurred. Transient knee pain affected 2, 3 and 5 participants across the low, moderate and high arms and delayed muscle soreness 2 and 4 in the moderate and high arms, all resolving within 48 to 72 hours with nobody withdrawing for an exercise-related reason. Adherence fell as intensity rose, 92, 89 and 85 percent.

  • Systematic review · 2019 · n=12

    Promising
    Impact of Exercise Therapy on Molecular Biomarkers Related to Cartilage and Inflammation in Individuals at Risk of, or With Established, Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Twelve RCTs, 57 comparisons at 4 to 24 weeks. Exercise therapy decreased molecular biomarkers in 17 comparisons (30%), left them unchanged in 36 (63%) and increased them in 4 (7%). Meta-analyses of nine biomarkers found non-significant reductions in C-reactive protein, CTX-II, TNF-alpha, soluble TNF receptors 1 and 2, C2C and cartilage oligomeric matrix protein against non-exercising controls, and no effect on interleukin-6 or its soluble receptor. Change was detected more often in synovial fluid (50% of comparisons) than in blood (36%) or urine (20%), so the compartment sampled may matter as much as the marker.

Related entries

4 · chosen by hand

Other shelves

  • 07 · Precautions

    Overloading and rushed return

    Sharp pain, workload spikes, and going back too soon — not load itself

    Promising
  • 07 · Precautions

    Immobilization and disuse

    Cartilage thins within weeks of unloading — in bed rest, on crutches, after spinal cord injury

    Promising

This shelf